Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Gains from Investment Securities (2016 - 2025)

BioCorRx (BICX) has disclosed Gains from Investment Securities for 10 consecutive years, with $1.6 million as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities changed N/A to $1.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Sep 2025, changed N/A year-over-year, with the annual reading at $1.7 million for FY2025, 21.61% up from the prior year.
  • Gains from Investment Securities hit $1.6 million in Q3 2025 for BioCorRx, up from $1.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q3 2025 to a low of $10000.0 in Q2 2021.
  • Historically, Gains from Investment Securities has averaged $919635.4 across 4 years, with a median of $858101.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 86.21% in 2021 and later surged 8330.04% in 2022.
  • Year by year, Gains from Investment Securities stood at $818631.0 in 2021, then rose by 4.82% to $858101.0 in 2022, then grew by 3.89% to $891443.0 in 2023, then surged by 80.61% to $1.6 million in 2025.
  • Business Quant data shows Gains from Investment Securities for BICX at $1.6 million in Q3 2025, $1.5 million in Q2 2025, and $891443.0 in Q3 2023.